In terms of the Company's Code of Conduct to Regulate, Monitor and report Trading by Insiders, framed pursuant to SEBI(Prohibition of Insider Trading ) Regulations, 2015 read with SEBI(Prohibition of Insider Trading(Amendment) Regulations,2018, Godavari Drugs has informed that the Trading Window for carrying out transaction in the shares of the company for all designated persons and their immediate relatives shall remain closed with effect from July 1,2025, for the purpose of declaration of Unaudited Financial Results for the First Quarter ended on June 30,2025. The Trading window shall reopen after 48 hours from the announcement of the Unaudited Financial Results for the First Quarter ended June 30,2025 to the Stock Exchange. The date of Meeting of the Board of Directors to approve the Unaudited Financial Results for the First Quarter ended June 30,2025 will be informed in due course.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1820.75 |
| Dr. Reddys Lab | 1270.95 |
| Cipla | 1333.55 |
| Zydus Lifesciences | 911.85 |
| Lupin | 2343.40 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: